(Q36364988)

13 August 2017

1 reference

title

DNA damage and tumor surveillance: one trigger for two pathways (English)

1 reference

13 August 2017

0 references

Petter Höglund

1

1 reference

13 August 2017

10 January 2006

1 reference

Science's STKE : signal transduction knowledge environment

13 August 2017

1 reference

13 August 2017

2006

1 reference

13 August 2017

317

1 reference

13 August 2017

pe2

1 reference

DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

13 August 2017

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

Surveillance against tumors--is it mainly immunological?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

Novel cancer therapy by reactivation of the p53 apoptosis pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

Roles of the NKG2D immunoreceptor and its ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

NKG2D-DAP10 triggers human NK cell–mediated killing via a Syk-independent regulatory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

MIC and other NKG2D ligands: from none to too many.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

Induction and utilization of an ATM signaling pathway by polyomavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

Regulation of cutaneous malignancy by gammadelta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

NKG2D function protects the host from tumor initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

A fresh look at tumor immunosurveillance and immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

The immunobiology of cancer immunosurveillance and immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

A listing of human tumor antigens recognized by T cells: March 2004 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

Recent developments in therapeutic cancer vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.3172006PE2

21 January 2018

Identifiers

DOI

10.1126/STKE.3172006PE2

1 reference

13 August 2017

1 reference

PubMed ID

16403940